Market closedNon-fractional
Dr Martens /DOCS
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About Dr Martens
Ticker
DOCS
Sector
Consumer Cyclicals
Trading on
LSE
Industry
Textiles, Apparel and Luxury Goods
Headquarters
London, United Kingdom
Employees
2,630
Website
www.drmartensplc.com
Dr Martens Metrics
BasicAdvanced
£661M
Market cap
9.82
P/E ratio
£0.07
EPS
0.07
Beta
£0.03
Dividend rate
3.71%
Dividend yield
Price and volume
Market cap
£661M
Beta
0.07
Dividend rate
£0.03
Financial strength
Current ratio
2.848
Quick ratio
1.136
Long term debt to equity
114.503
Total debt to equity
127.268
Dividend payout ratio (TTM)
83.53%
Interest coverage (TTM)
3.93%
Management effectiveness
Return on assets (TTM)
8.12%
Return on equity (TTM)
17.92%
Valuation
Price to earnings (TTM)
9.821
Price to revenue (TTM)
0.771
Price to book
1.8
Price to tangible book (TTM)
6.73
Price to free cash flow (TTM)
4.847
Dividend yield (TTM)
3.71%
Growth
Revenue change (TTM)
-12.32%
Earnings per share change (TTM)
-45.67%
3-year revenue growth (CAGR)
4.30%
3-year earnings per share growth (CAGR)
26.35%
What the Analysts think about Dr Martens
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.
Dr Martens Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Dr Martens Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Dr Martens News
AllArticlesVideos
DOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
PRNewsWire·3 months ago
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
PRNewsWire·3 months ago
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
PRNewsWire·3 months ago
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG
Market closedNon-fractional
Upcoming events
Aug
29
Dr Martens
Dividend·Ex-dividend
Oct
1
Dr Martens
Dividend·Payment
£0.0099
Per share
FAQs
What’s the current market cap for Dr Martens stock?
Dr Martens (DOCS) has a market cap of £661M as of July 27, 2024.
What is the P/E ratio for Dr Martens stock?
The price to earnings (P/E) ratio for Dr Martens (DOCS) stock is 9.82 as of July 27, 2024.
Does Dr Martens stock pay dividends?
Yes, the Dr Martens (DOCS) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is £0.0255 and the yield is 3.71%. Dr Martens has a payout ratio of 83.53% on a trailing twelve-month basis.
When is the next Dr Martens dividend payment date?
The next Dr Martens (DOCS) dividend payment is scheduled for October 01, 2024.
What is the beta indicator for Dr Martens ?
Dr Martens (DOCS) has a beta rating of 0.07. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Dr Martens stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.